[go: up one dir, main page]

Follow
Ki Duk Park
Ki Duk Park
Verified email at kist.re.kr - Homepage
Title
Cited by
Cited by
Year
Discovery of vinyl sulfones as a novel class of neuroprotective agents toward Parkinson’s disease therapy
SY Woo, JH Kim, MK Moon, SH Han, SK Yeon, JW Choi, BK Jang, ...
Journal of medicinal chemistry 57 (4), 1473-1487, 2014
2772014
Severe reactive astrocytes precipitate pathological hallmarks of Alzheimer’s disease via H2O2 production
H Chun, H Im, YJ Kang, Y Kim, JH Shin, W Won, J Lim, Y Ju, YM Park, ...
Nature neuroscience 23 (12), 1555-1566, 2020
2732020
Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer’s disease
JH Park, YH Ju, JW Choi, HJ Song, BK Jang, J Woo, H Chun, HJ Kim, ...
Science advances 5 (3), eaav0316, 2019
1912019
α-Pinene, a major constituent of pine tree oils, enhances non-rapid eye movement sleep in mice through GABAA-benzodiazepine receptors
H Yang, J Woo, AN Pae, MY Um, NC Cho, KD Park, M Yoon, J Kim, ...
Molecular pharmacology 90 (5), 530-539, 2016
1522016
Aberrant tonic inhibition of dopaminergic neuronal activity causes motor symptoms in animal models of Parkinson’s disease
JY Heo, MH Nam, HH Yoon, J Kim, YJ Hwang, W Won, DH Woo, JA Lee, ...
Current Biology 30 (2), 276-291. e9, 2020
1392020
Astrocytes control sensory acuity via tonic inhibition in the thalamus
H Kwak, W Koh, S Kim, K Song, JI Shin, JM Lee, EH Lee, JY Bae, GE Ha, ...
Neuron 108 (4), 691-706. e10, 2020
1372020
Activation of astrocytic μ-opioid receptor causes conditioned place preference
MH Nam, KS Han, J Lee, W Won, W Koh, JY Bae, J Woo, J Kim, E Kwong, ...
Cell reports 28 (5), 1154-1166. e5, 2019
1172019
Synthesis of 13-(substituted benzyl) berberine and berberrubine derivatives as antifungal agents
KD Park, JH Lee, SH Kim, TH Kang, JS Moon, SU Kim
Bioorganic & medicinal chemistry letters 16 (15), 3913-3916, 2006
1132006
Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model
S Kim, ANI Viswanath, JH Park, HE Lee, AY Park, JW Choi, HJ Kim, ...
Neuropharmacology 167, 107989, 2020
1102020
Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors
JW Choi, BK Jang, N Cho, JH Park, SK Yeon, EJ Ju, YS Lee, G Han, ...
Bioorganic & Medicinal Chemistry 23 (19), 6486-6496, 2015
1042015
Useful tools for biomolecule isolation, detection, and identification: acylhydrazone-based cleavable linkers
KD Park, R Liu, H Kohn
Chemistry & biology 16 (7), 763-772, 2009
1012009
Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives
JM Song, KD Park, KH Lee, YH Byun, JH Park, SH Kim, JH Kim, ...
Antiviral Research 76 (2), 178-185, 2007
992007
CRISPR/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide
A Moutal, X Yang, W Li, KB Gilbraith, S Luo, S Cai, L François-Moutal, ...
Pain 158 (12), 2301-2319, 2017
942017
In silico docking and electrophysiological characterization of lacosamide binding sites on collapsin response mediator protein-2 identifies a pocket important in modulating …
Y Wang, JM Brittain, BW Jarecki, KD Park, SM Wilson, B Wang, R Hale, ...
Journal of Biological Chemistry 285 (33), 25296-25307, 2010
902010
Excessive astrocytic GABA causes cortical hypometabolism and impedes functional recovery after subcortical stroke
MH Nam, J Cho, DH Kwon, JY Park, J Woo, JM Lee, S Lee, HY Ko, ...
Cell reports 32 (1), 2020
882020
Synthesis and Anticonvulsant Activities of (R)-N-(4′-Substituted)benzyl 2-Acetamido-3-methoxypropionamides
C Salomé, E Salomé-Grosjean, KD Park, P Morieux, R Swendiman, ...
Journal of medicinal chemistry 53 (3), 1288-1305, 2010
782010
N-Benzylbenzamides: a new class of potent tyrosinase inhibitors
SJ Cho, JS Roh, WS Sun, SH Kim, KD Park
Bioorganic & medicinal chemistry letters 16 (10), 2682-2684, 2006
782006
(S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation …
A Moutal, LA Chew, X Yang, Y Wang, SK Yeon, E Telemi, S Meroueh, ...
Pain 157 (7), 1448-1463, 2016
712016
Indole-substituted benzothiazoles and benzoxazoles as selective and reversible MAO-B inhibitors for treatment of Parkinson’s disease
MH Nam, M Park, H Park, Y Kim, S Yoon, VS Sawant, JW Choi, JH Park, ...
ACS chemical neuroscience 8 (7), 1519-1529, 2017
662017
Optimization of vinyl sulfone derivatives as potent nuclear factor erythroid 2-related factor 2 (Nrf2) activators for Parkinson’s disease therapy
JW Choi, S Kim, JH Park, HJ Kim, SJ Shin, JW Kim, SY Woo, C Lee, ...
Journal of Medicinal Chemistry 62 (2), 811-830, 2018
652018
The system can't perform the operation now. Try again later.
Articles 1–20